Vivos Inc (RDGL): FDA oncology chief aims to open up accel...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: None

Thursday, 04/07/2022 1:43:18 PM

Thursday, April 07, 2022 1:43:18 PM

FDA oncology chief aims to open up accelerated approval for earlier cancer treatment under 'Project FrontRunner'

https://www.fiercebiotech.com/biotech/fda-oncology-chief-eyes-accelerated-approval-earlier-cancer-treatment-under-planned-project

Keep Last Read

Replies (1) Next 10 Prev Next

Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 06:28:50 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 09:30:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:40:48 PM
Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 12/07/2023 05:15:10 AM
Form 1-A POS - • Edgar (US Regulatory) • 11/27/2023 10:29:12 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 04:28:46 PM
Form 1-A POS - • Edgar (US Regulatory) • 11/03/2023 09:03:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 04:18:34 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 10:33:58 AM
Form 1-A POS - • Edgar (US Regulatory) • 10/10/2023 04:05:36 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 07:22:21 PM

InvestorsHub NewsWire

FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM

Only $200 per official company press release!